Fleury

In 1926, Gastão Fleury, a professor at the University of São Paulo's Faculty of Medicine, along with his colleague Walter Egydio de Salles, opened a small clinical analysis laboratory in the center of São Paulo. Their vision was to bring a new level of scientific rigor and quality to the city's medical diagnostics. This foundational commitment to excellence would become the company's enduring playbook. The business began by focusing on a few specialized tests, building a reputation among the local medical community. For decades, Fleury grew organically, establishing itself as a benchmark for quality and innovation in Brazilian medicine. A significant turning point came in the 1970s and 80s as the company pioneered the concept of integrated diagnostic medicine, bringing various specialties under one roof. This customer-centric approach, offering everything from clinical analyses to imaging in a single location, was a game-changer for patient convenience and care coordination. The next major chapter in the company's journey was its strategic decision to go public. In December 2009, Fleury Group held its Initial Public Offering (IPO) on the B3 stock exchange in São Paulo, marking a new era of expansion and corporate governance. This infusion of capital fueled a wave of acquisitions and the expansion of its service network across Brazil, solidifying its position not just as a laboratory, but as a comprehensive health platform. Today, Fleury stands as a titan of the Latin American healthcare industry, a testament to a nearly century-old vision of scientific precision and patient focus.